Moreover, IFN (particularly type I IFNs) responses have recently been postulated as a central immunological axis that governs adipocyte differentiation and T cell pathogenicity during obesity-associated metabolic disease [107,108,109]. Here, IFNA1 is linked to metabolic disease.